Liver Cirrhosis

The Liver Cirrhosis Study is designed to evaluate patients with advanced liver scarring caused by chronic liver diseases. Cirrhosis affects the liver’s ability to function properly, leading to complications such as fluid buildup, infections, and liver failure. This study helps identify early signs of progression and test new treatment options aimed at improving liver health and patient outcomes.

1. Liver Function and Enzyme Testing

• Measures key enzymes and proteins to assess how well the liver is working.

• Detects early signs of worsening liver damage or inflammation.
  
  

2. Imaging and Fibrosis Assessment

• Uses ultrasound, FibroScan, or MRI to visualize the degree of scarring and structural changes.

• Provides accurate staging of cirrhosis progression and response to therapy.
  
  

3. Symptom and Complication Monitoring

• Tracks symptoms such as fatigue, jaundice, and fluid retention.

• Helps detect potential complications like portal hypertension or hepatic encephalopathy early.
  
  

4. Investigational Treatment Evaluation

• Participants may receive new medications or therapies targeting liver regeneration and fibrosis reversal.

• Regular follow-ups ensure safe and effective treatment outcomes.
  
  

Eligible Participants Are

• 18 to 75 years of age

• Diagnosed with liver cirrhosis (compensated or decompensated)

• Cirrhosis caused by chronic liver disease (hepatitis, alcohol use, NASH, or other causes)

• Experiencing symptoms or complications related to liver scarring

• Willing to undergo liver imaging, blood tests, and possible liver biopsy

• Additional criteria apply
  
  

Eligible Participants May

• Receive study-related medical care and treatment at no cost

• Receive compensation for study-related time and travel

• Gain access to investigational therapies for liver cirrhosis

• Contribute to advancing liver disease research and patient care
  
  

The Liver Cirrhosis Clinical Trial contributes to the advancement of modern therapies designed to slow or reverse liver scarring. By joining this study, participants play a crucial role in helping medical professionals find better solutions for chronic liver disease management.